“Omalizumab Improves Angioedema-Related Quality of Life Impariment in Patients with Chronic Idiopathic/Chronic Spontaneous Urticaria: Results from the X-Act Study” (2018) SKIN The Journal of Cutaneous Medicine, 2(S1), p. S53. doi:10.25251/skin.2.supp.53.